Tenaya Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio1.221.580.532.81
Price/Tangible Book1.221.580.532.81
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-0.96%-0.65%-0.47%-0.35%-0.46%
Return on Assets (ROA)-0.50%-0.36%-0.26%-0.20%-0.26%
Return on Capital Employed (ROCE)-1.11%-0.89%-0.49%-0.25%-0.27%
Leverage & Solvency Ratios
Debt/Equity0.150.090.060.06
Liquidity Ratios
Current Ratio4.224.917.9911.7325.78
Quick Ratio3.854.607.7911.5425.50
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-0.98%-0.56%-0.96%-0.09%
FCF Yield-0.81%-0.47%-0.97%-0.11%
Buyback Yield-0.15%-0.65%-1.53%-17.24%-0.29%